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Background: To eliminate new pediatric HIV infections, interventions that facilitate adherence, including
those that minimize stigma, enhance social support, and mitigate the influence of poverty, will likely be
required in addition to combination antiretroviral therapy (ART). We examined the relationship between
partner testing and infant outcome in a prevention of parent-to-child transmission of HIV program, which
included a family-centered case management approach and a supportive environment for partner disclosure
and testing.
Design: We analyzed routinely collected data for women and infants who enrolled in the parent-to-child
transmission of HIV program at Goroka Family Clinic, Eastern Highlands Provincial Hospital, Papua New
Guinea, from 2007 through 2011.
Results: Two hundred and sixty five women were included for analysis. Of these, 226 (85%) had a partner, 127
(56%) of whom had a documented HIV test. Of the 102 HIV-infected partners, 81 (79%) had been linked to
care. In adjusted analyses, we found a significantly higher risk of infant death, infant HIV infection, or loss to
follow-up among motherinfant pairs in which the mother reported having no partner or a partner who was
not tested or had an unknown testing status. In a second multivariable analysis, infants born to women with
more time on ART or who enrolled in the program in later years experienced greater HIV-free survival.
Conclusions: In a program with a patient-oriented and family-centered approach to prevent vertical HIV
transmission, the majority of women’s partners had a documented HIV test and, if positive, linkage to care.
Having a tested partner was associated with program retention and HIV-free survival for infants. Programs
aiming to facilitate diagnosis disclosure, partner testing, and linkage to care may contribute importantly to
the elimination of pediatric HIV.
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A
s part of the Global Plan Toward Elimination of
New HIV Infections Among Children By 2015
and Keeping Mothers Alive, UNAIDS set a goal
of reducing new HIV infections among children by 90%
between 2011 and 2015 (1). Chief among the requisites
for achieving this target are widely accessible, effective
programs to provide antiretroviral therapy (ART) to
HIV-infected pregnant women early in pregnancy, and
to those desiring children (1). While the effectiveness of
ART for the prevention of mother-to-child transmission
of HIV (PMTCT) is clear, many programs report high
rates of loss to follow-up (2, 3) and struggle to achieve the
52% transmission rates that have been shown to be
attainable (410). Highly variable PMTCT success rates
across programs likely represent the complex, multi-
faceted factors that contribute to access to care and early
initiation of and adherence to ART (1114). They also
suggest that, in order to further drive down transmission
rates, some PMTCT programs may need to incorporate
interventions aimed at curtailing the effects of stigma,
enhancing social support, and reducing the influence of
poverty.
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promising strategy to further reduce HIV vertical trans-
mission and improve infant survival (15, 16). Greater
uptake of PMTCT interventions and adherence to the
feeding option of choice has been demonstrated with
male partner involvement (1722). Nonetheless, the HIV
disclosure process may be complex, and some women
may feel unequipped to disclose in the absence of
additional support (23). By disclosing her HIV status to
her partner, a woman may put herself at risk for violence
(2325); abandonment  this fear may be especially acute
for women in polygamous relationships (23, 24, 26); and
loss of reputation (27) or material or economic support
(23, 24, 26). In Tanzania, reliance on a partner for
expenditures such as food, rent, or school fees was
associated with lower rates of HIV diagnosis disclosure
(28). Once disclosure does occur, barriers for HIV testing
among male partners include the perception of PMTCT
clinics as a woman’s place (29, 30); the time required for
testing, which may interfere with employment (31); and
fear that he will be blamed for introducing HIV into the
family.
In 2006, the Papua New Guinea (PNG) Department of
Health and Clinton Health Access Initiative developed a
rural service delivery model to provide HIV care and
treatment in rural PNG. Now termed the Patient and
Provider Unified Approach (PAPUA), the model seeks to
address important patient barriers to health, including
difficult access to health care, HIV-related stigma, and
extreme poverty, while also emphasizing the need for
stronger provider support through training, mentorship,
and supervision (32). PAPUA includes a comprehensive,
case managementled PMTCT program, which provides
support in diagnosis disclosure to partners and outreach
to partners and children for testing and support. In 2007,
the government of PNG replaced the conventional no-
menclature ‘‘Prevention of Mother-to-Child Transmission
of HIV’’ with ‘‘Prevention of Parent-to-Child Transmis-
sion of HIV’’ (PPTCT). At that time, national antenatal
HIV-testing rates were low (33), and there was a fear
among health workers and leaders that pregnant women
diagnosed with HIV could be blamed or victimized by
their male partners or families and face physical violence
or indirectly violent exclusionary behavior (34). Replacing
the word ‘‘mother’’ with ‘‘parent’’ was intended to both
acknowledge the role of the male partner in the process of
prevention of vertical transmission and lighten any
potential stigma for women. To our knowledge, there are
nopublishedpapersexaminingPPTCToutcomes inPNG,
let alone in the rural areas, where the majority of HIV-
infected persons in PNG reside (35). The objectives of this
study were to quantify the uptake of HIV testing and care
among partners of HIV-infected pregnant women receiv-
ing care in this program, to examine the relationship
betweenpartner testing status and program retention with
infant HIV-free survival, and to identify other factors
associated with HIV-free survival.
Methods
Study setting
PNG, an island of 7 million inhabitants, has the highest
burden of HIV in the South Pacific (36). In the country’s
rural Highlands areas, PPTCT is particularly challenging
due to high rates of HIV-related stigma, gender inequal-
ity, and poverty (37). Polygamy, concurrent partnerships,
and intimate partner violence are common in these areas
(34, 38, 39). This study was conducted in the Eastern
Highlands Province, where the life expectancy is 55 years,
44% of adults are literate, and only 45% of the population
lives within 5 km of a national roadway (40).
Study population
Included in this analysis were all women who were
registered for PPTCT services at any time during
pregnancy, including during labor, from 2007 through
2011 at Goroka Family Clinic at the Eastern Highlands
Provincial Hospital, PNG. We excluded women for any
of the following reasons: 1) her chart could not be
located; 2) her infant’s chart could not be located, and
infant status could not be determined; or 3) she was
found not to be pregnant or not to be HIV infected.
Women and infants who presented to the clinic for the
first time after delivery were not enrolled in the PPTCT
program, but rather treated through the pediatric clinic.
Therefore, these women and their infants were not in-
cluded in this study.
PPTCT standard of care throughout the study period
The PNG National Guidelines for HIV Care and Treat-
ment were used to direct clinical care and ART for
pregnant women during the study period (41). The
recommended first-line triple-therapy regimen for HIV-
infected pregnant women requiring ART for their own
health or PPTCT was zidovudine, lamivudine, and nevi-
rapine. Guidelines for PPTCT during the study period
were as follows. Prior to 2009, guidelines indicated that
women who did not require ART for their own health be
commenced on daily single-dose zidovudine, followed by
intrapartum and ‘‘tail’’ doses of lamivudine and nevi-
rapine. After 2009, women were recommended to initiate
triple therapy after 28 weeks of gestation. Women who
did not initiate triple therapy during pregnancy were
given a single dose of nevirapine plus lamivudine and
zidovudine at the onset of labor, followed by a single dose
ofnevirapinetotheinfant.Fourtosixweeksofzidovudine
wasprescribedtoallinfants.Throughoutthestudyperiod,
it was recommended that women receiving triple therapy
for PPTCTcontinue it for the duration of breastfeeding to
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mended for women attending antenatal clinic throughout
the study period, with opt-out testing beginning in 2007.
Partner testing was recommended for women enrolled in
PPTCT services beginning in 2009.
Partner testing and case management in PAPUA
This PPTCT program was part of a provincial networkof
centrally-coordinated decentralized HIV service delivery
centers (32). Antenatal testing for HIV, syphilis, and
hemoglobin was provided by linked clinics serving the
populaceofEasternHighlandsin20locations,10ofwhich
also provided adult ART. HIV-infected pregnant women
were referred to a central antenatalPPTCTpediatric
clinic, located at the provincial hospital in the capital city.
As part of PAPUA, PPTCT services were structured
around treatment of the HIV-infected woman and all of
her family members, unless the woman chose not to
disclose her diagnosis. Focus on the family, particularly
malepartners,withinthemother’scarewasappropriatefor
the local Highlands cultures, where men usually make
decisions, yet women providemost of the supporting work
(42). The addition of a case management system to the
usual clinical care aimed to assure linkages; provide
ongoing, in-depth patient counseling; remove material
obstacles to care; and ensure a higher quality care. Case
managers aimed to build a trusting environment where
women could feel supported and safe enough to consider
disclosure of their HIV status to male partners and
possiblytootherfamilymembers.Afterinitialrelationship
building, case managers encouraged women to bring in
theirmalepartnersandchildrenforcounselingandtesting.
Case managers would sometimes test women and their
male partners together as if the woman had not yet been
tested. Some women selected this approach because it
allowed for both partners’ results to be reported at the
same time and with the presence and support of the case
manager, which could minimize accusations and blame.
Synchronization and consolidation of clinical appoint-
mentswith regular antenatal serviceswas a cornerstone of
case management and allowed for appointments for
antenatal and HIV care to occur on the same day and in
the same place for women, HIV-infected male partners,
and HIV-exposed infants. This approach was especially
valuable to families traveling from farther districts within
the province, as it required only one monthly visit per
family. Women and families received reimbursement
for transportation costs, as well as modest nutritional
support, and family-sized mosquito nets.
Data collection
We conducted a retrospective review of existing program-
matic and clinical records. The PPTCT registration book
was used to identify women eligible for inclusion in these
analyses. Data from mothers’, infants’, and partners’
paper charts were reviewed and transcribed to standard-
ized study forms, using electronic data and clinician
interviews to fill in gaps as needed.
Definitions
Partner status was classified into three categories: no
partner, tested partner, and partner who was untested or
had an unknown testing status. Program completion was
determined as follows: for replacement-fed infants, an
HIV-negativeHIVDNApolymerasechainreaction(PCR)
testafter6weeksofagewasrequired;forbreastfedinfants,
an HIV-negative test 6 weeks after the wean date was
required, and, if no wean date was available, either two
negative tests or one negative test after 15 months of age
was required. Infants who died, mothers who became lost
to follow-up during pregnancy, and motherinfant pairs
who were lost after delivery were not considered to have
successfully completed the program. Partners were deter-
mined to have been linked to care if they could be found
in the HIV registry or had a chart in an adult HIV clinic.
IntheabsenceofanARTstartdateindicatingthecontrary,
women who were on ART for their own health previously
wereassumedtohavebeenontreatmentforthedurationof
their pregnancy.
Statistical analysis
We conducted regression analyses to examine the rela-
tionship between partner testing status and the study
outcome: program retention with HIV-free survival and
its inverse (i.e. lost to follow-up, infant death, or infant
HIV infection). We estimated risk ratios using the simple
strategy proposed by Tchetgen Tchetgen (43). Women
who experienced a stillbirth, motherinfant pairs who
transferred out of the program, and motherinfant pairs
for whom we lacked an infant chart or partner data were
excluded from multivariable analyses. Because having a
tested partner may influence a woman’s decisions about a
number of issues on the causal pathway to infant health
outcomes (i.e., earlier presentation to the clinic, longer
time on ARTat delivery, more antenatal visits, and better
adherence to treatment), we adjusted only for maternal
age, time with HIV diagnosis at the first antenatal visit
(greater than or less than 1 year), and year of program
enrollment. Missing covariate datawere multiply imputed
using Markov chain Monte Carlo methods to complete
the data set. We used the same procedures to conduct a
secondary analysis of other factors associated with infant
HIV-free survival. For this analysis, we additionally
excluded women who became lost to follow-up, either
prior to or after delivery. Any variable associated with
HIV-free survival at a pB0.20 in univariable analyses was
included in the multivariable analyses. When variables
were correlated, we retained that most strongly associated
with the outcome. Analyses were conducted using SAS
version 9.12 (SAS Institute, Cary, NC, USA).
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Two-hundred eighty-seven women were registered for
PPTCT services during the study period. Of these, charts
could not be located for 20. Additionally, one woman was
determined not to be pregnant, and one was determined
to be HIV-negative. An overview of the motherinfant
pairs comprising the study cohort is shown in Figure 1.
Characteristics of the 265 women included for analysis
are shown in Table 1. The median age was 24 years
(interquartile range [IQR]: 2129). Women tended to
present to the PPTCT clinic late in gestation with a
median gestational age of more than 6 months at the time
of the first visit (median: 197.5 days; IQR: 153.5232.5).
Women received ART for a median of 83 days prior to
delivery (IQR: 22274), and 12.0% of women received
only single-dose nevirapine or did not receive an ART
intervention. Gestational age at first antenatal visit and
time on ART before delivery were inversely correlated
(correlation0.43, pB0.0001). The number of women
registered for PPTCT was greater in later years.
HIV testing uptake and linkage to care
Figure 2 shows the rate of uptake of HIV testing among
partners and their linkage to care. Among the 265
women, partner data were available for 261 (98%). Of
these, 35 (13%) reported no partner. Of the 226 women
with a partner, 127 partners (56%) had an HIV test result,
102 (80%) of which were positive. The vast majority of
HIV-infected partners (79%) had a documented linkage
to care. On average, women were 5 years younger than
their HIV-infected partners (range 536). Reasons for
no HIV testing among partners were not generally avail-
able but were noted for 22 women and included living
apart from the partner (n13), not wanting to disclose
to the partner (n8), and having a partner who did not
want to be tested (n1).
Partner testing and program retention with
HIV-free survival
Nine women whose infants were stillborn, four who
transferred out of the program prior to completion, three
with infants for whom we lacked a chart, and four women
lacking data on partner information were excluded from
multivariable analyses. Among 245 motherinfant pairs,
150 women successfully completed the program with an
infant who was alive and documented as HIV-free.
Partner status (i.e. no partner, tested partner, partner
not tested, or partner with an unknown status) was not
associated with maternal age (Kruskal Wallis p0.20),
but was associated with time since HIV diagnosis.
Individuals with a tested partner were more likely to
have had their HIV diagnosis for at least a year, whereas
individuals with an untested partner or a partner of
unknown HIV status were more likely to have been
diagnosed in the 12 months prior to PPTCT enrollment
(chi-squared p0.001). Not having a partner or having a
partner who was not tested or had an unknown testing
status was associated with an increased risk of loss to
follow-up, infant death, or infant HIV infection in both uni-
variable analysis and a multivariable analysis adjusting
287 women registered
Chart could not be located (N=20)
Not pregnant (N=1)
HIV negative (N=1)
265 women included for
analysis
Still births (N=9)
Unknown pregnancy outcomes 
(N=10, all women were lost-to-follow-up)
246 women with a
pregnancy outcome
No infant data available (N=3) 
243 live births
42 (17%)
died or HIV-
infected *
9 (4%)
lost to 
follow-up
150 (62%) confirmed HIV
negative and completed the
program
4 (2%)
transferred out
3 (1%) completed
without testing
confirmation
35 (14%) with 
incomplete testing;
initial DBS negative
*Of these, 11 received no ART intervention, single-dose
nevirapine, or zidovudine only and 5 lacked regimen data.
Fig. 1. Overview of PPTCT registration and outcomes, Eastern Highlands Province, Papua New Guinea, 20072011.
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natal visit, and year of program enrollment (Table 2).
Factors associated with HIV-free survival
Table 3 shows factors associatedwith HIV-free survival in
univariable and multivariable analyses. Among the 230
women included, 42 gave birth to infantswho later died or
were confirmed to be HIV infected (Fig. 1). In univariable
analysis,longertime onART,lateryearofprogram enroll-
ment, having initiated ART for her own health, and a
greater number of antenatal visits were all positively asso-
ciated with infant HIV-free survival, whereas older gesta-
tional age at first antenatal visit was negatively associated
with HIV-free survival. In multivariable analysis, longer
time on ART and later year of program enrollment were
positively associated with HIV-free survival. Excluding
motherinfant pairs who were lost to follow-up, infants
borntothe67womenwhohadmorethan24weeksofART
had an HIV-free survival percentage of 96%. In contrast,
the 45 infants born to women with an unknown ART
duration and the 34 infants born to women with less
than 1 week of ART had HIV-free survival percentages of
60 and 62%, respectively.
Discussion
In the context of a PPTCT program that included a case
management intervention to facilitate diagnosis disclo-
sure to partners and encourage partner testing, a high
Table 1. Characteristics of 265 women registered for prevention of parent-to-child HIV transmission services in Goroka, Papua
New Guinea
Variable N with data N (%) or median (IQR)
Age (years) 259 24 (2129)
Time from diagnosis to first antenatal visit (days) 224 53 (8.5509)
Gestational age at first antenatal visit (days) 200 197.5 (153.5232.5)
Number of antenatal visits 265 4 (27)
Initiated ART for own health 250 75 (30.0)
Antiretroviral regimen 250
ZDV, 3TC, NVP 163 (65.2)
D4T, 3TC, NVP 39 (15.6)
ZDV, 3TC, EFV 2 (0.8)
Triple therapy, unspecified 3 (1.2)
ZDV only 13 (5.2)
Single dose NVP 19 (7.6)
No ART
a 11 (4.4)
Time on ART prior to delivery (days) 211 83 (22274)
Ever had a suboptimal adherence assessment (B95% adherence) 247 18 (7.3)
CD4 count during pregnancy 132 276 (217.5380.5)
Lymphocyte count during pregnancy 152 1300 (10001900)
HIV stage before delivery 160
1 127 (79.4)
2 18 (11.3)
3 13 (8.1)
4 2 (1.3)
Year of first antenatal visit 246
2007 19 (7.7)
2008 40 (16.3)
2009 62 (25.2)
2010 72 (29.3)
2011 53 (21.5)
Feeding method
b 196
Exclusive breastfeeding 136 (69.4)
Formula feeding 36 (18.4)
Mixed feeding 24 (12.2)
aSome women who had no record of ART prior to delivery may have received ART during delivery without it being recorded in the chart.
bAmong women who had a live birth.
IQRinterquartile range; ARTantiretroviral therapy; ZDVzidovudine; EFVefavirenz; NVPnevirapine.
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tested positive for HIV (80%). Among those partners
with an HIV diagnosis, the majority had linkage to care.
Furthermore, motherinfant pairs were more likely to
complete the program with infant HIV-free survival if the
mother had a tested partner. By demonstrating a positive
relationship between partner testing and infant health
outcomes, this study expands upon prior work indicating
that uptake of and adherence to PPTCT interventions
may be jeopardized by nondisclosure to male partners or
lack of male partner involvement (1922). Consistent
with our findings, Aluisio and colleagues found that
infants born to HIV-infected women whose male partners
attended antenatal clinic visits experienced improved
survival relative to infants born to HIV-infected women
whose partners did not attend antenatal clinic visits (15).
The success and uptake of couples HIV testing may
vary by setting and implementation strategy. Couples
counseling and testing and facilitated mutual disclosure,
in either the home or clinic setting, were found to be
acceptable in Kenya (44); however, a randomized trial
from Tanzania found that couples HIV testing, relative to
Missing data on partner status (N=4)
No partner (N=35)
Divorced/Separated (N=15)
Widowed (N=11)
Single (N=8)
Unknown (N=1)
Not tested or unknown (N=99)
HIV-negative (N=16)
Unknown test result (N=9)
Not linked or unknown (N=21)
265 women
226 (85%) women with a partner
127 (56%) partners tested 
102 (80%) partners tested HIV-
positive
81 (79%) HIV-positive partners
with documented linkage to care 
Fig. 2. Linkage to care among partners of women registered for PPTCT services, Eastern Highlands Province,
Papua New Guinea, 20072011.
Table 2. Partner-testing status and outcome of loss to follow-up, infant death, or infant HIV infection (N245)
a
N
Outcome of loss to follow-up, infant
death, or infant HIV infection
N (%)
Univariable OR
(95% CI) p
Multivariable OR
(95% CI)
b p
Has tested partner 118 35 (29.7) Reference  Reference
No partner 30 15 (50.0) 1.69 (1.07, 2.65) 0.02 1.59 (1.01, 2.51) 0.05
Has partner, not tested or unknown 97 47 (48.5) 1.63 (1.16, 2.31) 0.005 1.50 (1.05, 2.16) 0.03
aWomen with a stillbirth (N9), who were transferred out of the program prior to completion (N4), or for whom we lack an infant chart
(N3) or partner data (N4) were excluded from analysis.
bAdjusted for maternal age, time with HIV diagnosis at first antenatal visit (greater or less than 1 year), and year of enrollment.
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results (45). Additional strategies to facilitate male part-
ner participation in PPTCT services could include clinic
hours and physical spaces that are accommodating
and appealing to men, sensitization of both health care
providers and men to the importance of male partner
involvement in PPTCT, targeted messaging toward those
men least likely to participate in PPTCT, and interven-
tions, such as screening for domestic violence and mental
health problems, which may contribute to enhanced
family functioning (16, 30, 46, 47).
Women who did not have a partner and those whose
partner was not tested were the majority of the women
included in this analysis, and they represent key groups
that may need extra support in order to successfully
complete PPTCT programs. Pregnant women without a
partner may be widows, be victims of rape, or have had
transactionalsexoutsideofaformalrelationship.Allthree
of these scenarios indicate a high level of vulnerability that
may challenge the ability to access health services and
adhere to treatment. Though we lacked systematically
collecteddataonpartnerdisclosure,itispossiblethatmale
partners who were not tested or had unknown testing
status did not haveknowledge of their partners’diagnoses.
Furthermore, each woman must consider the benefits of
disclosureandpartnertestingagainstthepossiblenegative
consequences, which include suspected infidelity, loss of
sexual intimacy, conflict, stigma, violence, or loss of
community standing (24, 48).
Late presentation to the PPTCT program led to
suboptimal exposure to ART prior to delivery for some
women and posed a major challenge to PPTCT in this
setting. Longer time on ART prior to delivery was
strongly associated with better HIV-free survival. Among
those who had more than 24 weeks of ART prior to
delivery, 96% of infantswerealive and HIV-freewhen they
exited the program. Program maturation, changing treat-
ment guidelines, and greater confidence and experience
among providers may have contributed to improved HIV-
free survival over time. In addition to initiation of ART
early during pregnancy, ensuring an adequate drug supply
was another challenge that interfered with optimal ART
exposure for pregnant women. Three significant ART
stockouts occurred during the study period, and it likely
prevented timely initiation of some onto treatment and
interrupted therapy in some who had already commenced
treatment.
Beginning in 2007, a decentralized basic package of
antenatal testing for HIV, syphilis, and hemoglobin from
the referral hospital to 20 satellite district clinics was
rolled out throughout the study province. While this step
was critical to improving case finding for women in need
of PPTCT, additional services including ART, HIV-
appropriate delivery services, and partner testing were
not available at these district sites during the study
period. With programs reporting better uptake when
ART was provided at the same place as PPTCT services
(49, 50), we expect that the decentralization of the full
complement of PPTCTservices will further improve HIV-
free survival for infants in the program.
Linking records for mothers, infants, and partners
sometimesinvolvedtrackingpaperrecordsacrossmultiple
clinics and sites. Though largely successful, not all charts
could be located. Imperfect tracing and the tendency for
Table 3. Predictors of HIV-free survival (N230
a)
Univariable RR
(95% CI) p
Multivariable RR
(95% CI) p
Time on ART prior to delivery (weeks) 1.006 (1.003, 1.009) 0.0004 1.01 (1.00, 1.01) 0.005
Age (5-year increase) 1.06 (0.99, 1.13) 0.11 1.03 (0.97, 1.11) 0.35
Year of first antenatal visit 1.08 (1.03, 1.14) 0.004 1.06 (1.00, 1.13) 0.05
Gestational age at first antenatal visit (months)
b 0.97 (0.94, 1.00) 0.05
Number of antenatal visits 1.03 (1.01, 1.05) 0.001 1.02 (1.00, 1.04) 0.06
Ever had a suboptimal adherence assessment 0.95 (0.73, 1.24) 0.71
Feeding method
Mixed feeding Reference
Exclusive breastfeeding 0.99 (0.87, 1.13) 0.89
Formula feeding 0.97 (0.82, 1.15) 0.69
Initiated ART for her own health
b 1.22 (1.11, 1.35) B0.0001
aWomen with a stillbirth (N9), who were transferred out of the program prior to completion (N4), who were lost to follow-up (N19),
or for whom we lacked an infant chart (N3) were excluded from analysis. The sample size for the univariable risk ratios changed
depending on the number of women missing data for the predictor. The sample size was 230 for the multivariable analysis, which was
conducted on multiply imputed datasets.
bGestational age at first antenatal visit and initiation of ART for the woman’s own health were correlated with time on ART prior to delivery
and therefore not included in the final multivariable model.
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anonymity in HIV clinics likely resulted in underestimates
of true linkage-to-care rates. A second important limita-
tionofthisanalysisisthatwomenwithtestedpartnersmay
differ from women without tested partners in ways that
also influence program retention and adherence to med-
ication, such as familial support and livelihood security.
We lacked data on socioeconomic indicators, intrafamilial
violence, and family structure and therefore cannot dis-
count the possibility that unmeasured differences between
women with and without tested partners explain the
associations observed here. A third limitation is that, due
to a large amount of missing data among the partner-
testing data, we could not confirm which partners were
tested as part of the PPTCT case management partner-
testing program versusthrough another mechanism, when
partner HIV tests occurred relative to the pregnancy, and
when partners’ linkages to care occurred relative to the
pregnancy. It is possible that some HIV-infected men
encouraged their female partners to seek HIV testing and
treatment before or during pregnancy. Finally, the retro-
spective nature of this analysis led to substantial missing
dataforsomevariables,particularlydates.Inspite ofthese
limitations, the results presented here point to the im-
portance of partner engagement and the potential role of
robust partner-testing programs in the elimination of
perinatal transmission of HIV.
Conclusions
We found relatively high rates of partner testing among
HIV-infectedwomen in this setting. Pregnant women with
a tested partner were more likely to have a child who
completed the program and remained alive and HIV-
negative. When the primary purpose of HIV care and
treatment is prevention of vertical transmission of HIV,
with the secondary purpose of providing agateway to care
for parents, patient-oriented and family-centered compre-
hensive service delivery contributes to HIV-free infant
survival, PPTCT program completion, and linkage of
positive male partners into care. From the perspective that
healthy andwell-supported parents, mothers in particular,
are the building blocks for healthy children, PAPUA’s
approach to PPTCTmay have important lessons forother
such programs.
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